{"name":"Shanghai NK Cell Technology Co., LTD","slug":"shanghai-nk-cell-technology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNUTlBMXJCN0MzODBoT2JGaWdKaVZHSEh0NEY5RS0tXzY1MmlBeGszc2k1UkFDV25LRTlQNW56aVFMeWdMcGNkMGlIYTZXQlFGWURvYjhaRUYtUktSbkNJUy1BSGI5SjZVMkZHeEJmOFRqOThxazJFaUtMUldGWUM4TVdleDV3QnBjTWk3SGI5OU5qaWVRVUE?oc=5","date":"2026-02-12","type":"pipeline","source":"PharmTech.com","summary":"European Biotechs Impacting Treatment of Alzheimer’s Disease - PharmTech.com","headline":"European Biotechs Impacting Treatment of Alzheimer’s Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9VTi13cDQzMVdDNUptMG95SzJIQmZrd1J3dVlsSnotSHpDQmtTSzAySEw1TGd5SWhFNXJDOXVMUUFNaUdGallJc1pMeVdSR3BsdzFhaUFrelEtSlN2Y0Zj?oc=5","date":"2026-01-06","type":"trial","source":"Nature","summary":"Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization and phase I trial - Nature","headline":"Intrathecal CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent high-grade Glioma: preclinical characterization ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPQjJ2VUhMM1Q5LUpUZWtQbERDaUNmenM4b3htblk1Slk2eHdpRjVoNk5iWHZzZ2NBWkNlUi1SUFZacERUaHBRemU5cFdGSUk5b3JaeTFsYnM4VUxrd0ZoVFRpUEw1bE5VcjU5ZG9FUjc3dkNSZHNxTzNFR2VSR0xfQmNsbw?oc=5","date":"2025-10-07","type":"pipeline","source":"BioWorld News","summary":"Takeda ditches cell therapy business - BioWorld News","headline":"Takeda ditches cell therapy business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBseXQxVFZRZE5DTGQxSmlBUExxd1RLLWx2czl1MmtONVFjVk5CZ01VbmlBd041WHZacWduV0pqQ2pVZFllRm9HZXZMaHJFR29tQlFmbTJWWU1aaEc5c21J?oc=5","date":"2025-08-14","type":"trial","source":"Nature","summary":"Cryopreserved leukapheresis enables scalable and distributed CAR-T manufacturing: a multi-platform comparative study - Nature","headline":"Cryopreserved leukapheresis enables scalable and distributed CAR-T manufacturing: a multi-platform comparative study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNT05lS1lYY0Q5bFJOSG4xaFVkUTZRMnMybktFam53UFhmTkZITEJJVWluaWhkelBZVnBubWJIb1lNWHlrR0JDdHRCZ3lzb3VqY2pDZkxFeUh3Z21zQmtfZmljX29tSUR1LUtwNXFBdi1NSmw0dU5GRUcybjNtOFVHUVhJU3NFMElaU2d4YkhoQVF4NktLeFBnRlR1MDBqY1A5ekFyRVlURWdQcExlaF9xSC1UaklLTDQ5SHkzTzcwM09qZVZRcmUzWHFueDhrWHhtM2tla011cHZ0aGRtVURjZHVrNGd6Yjg2RGF6RHZreE5YZw?oc=5","date":"2025-06-26","type":"pipeline","source":"BioSpace","summary":"iPSC-CAR-NK Cell Therapy Clinical Result Published in Cell, Marking a Global Breakthrough in Autoimmune Disease Treatment - BioSpace","headline":"iPSC-CAR-NK Cell Therapy Clinical Result Published in Cell, Marking a Global Breakthrough in Autoimmune Disease Treatmen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNYXNVcGVCOUx3b0paRVYyNXYzOC1OUFF3RnJVaVZpUVdEZlN5M2pJYzdLZU5IWHdoSXd1SUltcFRQNjBmUldrTm5QaF9tSTVfemtSbVREVDMzcnZBb3U0TWVqc2oxS2dUZktaYWNzRDUxZ19IR21zRnRVU1VVelJhRFozX1FWV0pmNGItc3ZSQk5BX1VGVHNkRjFwQmlKN3doRmNOVA?oc=5","date":"2025-02-12","type":"pipeline","source":"BioWorld News","summary":"Biomissile’s multispecific antibodies harness NK cell engagers - BioWorld News","headline":"Biomissile’s multispecific antibodies harness NK cell engagers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNbzZ6UmtYRTZ2dEF2WjZrREVfTjNpZm5TVmlEdW5pb0FJUzNxS3ZhaHJlR3A5MG5lWV9PVUVsUFBtSTk2NFR1bzJnaW1aZ3daYkh1VlI3ZDdsNE44aHZWOHlhTkR1U1VIdU9mR1laOW10WTAwTU8yaTJIWURVcm9hY1FybFVWMGRLN01MY2hnaXdBdw?oc=5","date":"2024-11-25","type":"pipeline","source":"Frontiers","summary":"CD73: agent development potential and its application in diabetes and atherosclerosis - Frontiers","headline":"CD73: agent development potential and its application in diabetes and atherosclerosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE1rakdKb2hOS2U0VGJXNGtMV21yaG9LNDE2Tk85UWdrNEFUckJWMmNDdXk2QUktU0p3SFdkVnlfemJycjdvWVN4Yl80T0c1VEduSkNPeUlVWVlnMmE5TDREOVdQUldrNVRVSEpB?oc=5","date":"2024-10-29","type":"pipeline","source":"Wiley Online Library","summary":"Natural killer cell engagers: From bi-specific to tri-specific and tetra-specific engagers for enhanced cancer immunotherapy - Wiley Online Library","headline":"Natural killer cell engagers: From bi-specific to tri-specific and tetra-specific engagers for enhanced cancer immunothe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFByaHdhaURCaDZ1ZkVMOEZILXhjajV5T2VWYzNMRXF0bVNjUTJjaVl3cjdPZTFiT0M2QlQzbnROUGpwX2p1cTRueFEtMnlZamNvY0Z6aU4xV3BTTHNrYWRUTDdJRGN2eTgtZkV6WG43OA?oc=5","date":"2024-04-02","type":"pipeline","source":"Wiley Online Library","summary":"CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies - Qian - 2024 - Interdisciplinary Medicine - Wiley Online Library","headline":"CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies - Qian - 2024 - Interdisciplinary Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPSmZKSWxhRzIwV080NUN4UUcydEcwblZmSC0yd19yQ0dEREVhbW9ad05GXzlKaUQtVUh2RW10cW9NV1I0cEdGZ081N2FEU2hhSER4V1ZQWTVCOGZyUmwxcUJVT255MXVqWGdWZ3RtaHRCdmh6QndRd3NNa3huVC1GOXptaDFFXzhVXzNiTmIzZWU4bEtOcHNrRUlSa2Y1NHZzR1pnRzRhZzVjdUs4ZEhYWg?oc=5","date":"2023-04-03","type":"pipeline","source":"PR Newswire","summary":"Harbour BioMed Reports Full Year 2022 Financial Results - PR Newswire","headline":"Harbour BioMed Reports Full Year 2022 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOdExYanZlX1FWb2pHeTNRdWhPZllTM05VckJXMWJnamhzMVdfNURreTJZcmU3b19WM0lFRGRwbnNBblNhTHBnWXJzTnljaGpXMjNMdDJyTVRYbm56ZjhPbVJtZUtjUTNLTFU5YUJKSm1xVlhfeUhfeW0zQXFfblNWUFAtV2thaDdVSzhfUjM5MjBXWFZVZ3ZNQQ?oc=5","date":"2019-04-23","type":"trial","source":"BioProcess International","summary":"A Harmonized Approach to Data Integrity - BioProcess International","headline":"A Harmonized Approach to Data Integrity","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}